Fatal gestational trophoblastic disease: An analysis of treatment failures

John Robert Lurain III*, John I. Brewer, Michael T. Mazur, Elizabeth E. Torok

*Corresponding author for this work

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Forty-eight of 399 patients referred to the John I. Brewer Trophoblastic D isease Center of Northwestern University Medical School from 1962 to 1979 for treatment of gestational trophoblastic disease (invasive mole or choriocarcinoma) died. All patients who died had histologically documented metastatic choriocarcinoma. The time from pregnancy event to treatment was >4 months and/or the pretreatment human chorionic gonadotropin titer was >100,000 IU/L in 64% of these patients. Seventy-one percent of fatal cases developed in association with term pregnancies, abortions, or ectopic pregnancies rather than hydatidiform moles. Fifty percent of patients who died had metastases to the liver, brain, and/or peritoneal cavity when they first presented for treatment. The most common causes of death were hemorrhage from one or more metastatic sites (42%) and pulmonary insufficiency (31%). Factors primarily responsible for the treatment failures in these patients were: (1) presence of extensive disease at the time of initial treatment; (2) inadequate initial treatment; and (3) failure of presently used chemotherapy protocols in advanced disease. Secondary chemotherapy, radiation therapy to sites other than the brain, and adjuvant surgical procedures failed to improve survival in these high-risk patients.

Original languageEnglish (US)
Pages (from-to)391-395
Number of pages5
JournalAmerican journal of obstetrics and gynecology
Volume144
Issue number4
DOIs
StatePublished - Oct 15 1982

Fingerprint

Gestational Trophoblastic Disease
Treatment Failure
Choriocarcinoma
Invasive Hydatidiform Mole
Time-to-Pregnancy
Therapeutics
Drug Therapy
Hydatidiform Mole
Ectopic Pregnancy
Peritoneal Cavity
Brain
Chorionic Gonadotropin
Medical Schools
Cause of Death
Radiotherapy
Hemorrhage
Neoplasm Metastasis
Pregnancy
Lung
Survival

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Lurain III, John Robert ; Brewer, John I. ; Mazur, Michael T. ; Torok, Elizabeth E. / Fatal gestational trophoblastic disease : An analysis of treatment failures. In: American journal of obstetrics and gynecology. 1982 ; Vol. 144, No. 4. pp. 391-395.
@article{edc90cacf49d4d2386fdfa47cc7a13d1,
title = "Fatal gestational trophoblastic disease: An analysis of treatment failures",
abstract = "Forty-eight of 399 patients referred to the John I. Brewer Trophoblastic D isease Center of Northwestern University Medical School from 1962 to 1979 for treatment of gestational trophoblastic disease (invasive mole or choriocarcinoma) died. All patients who died had histologically documented metastatic choriocarcinoma. The time from pregnancy event to treatment was >4 months and/or the pretreatment human chorionic gonadotropin titer was >100,000 IU/L in 64{\%} of these patients. Seventy-one percent of fatal cases developed in association with term pregnancies, abortions, or ectopic pregnancies rather than hydatidiform moles. Fifty percent of patients who died had metastases to the liver, brain, and/or peritoneal cavity when they first presented for treatment. The most common causes of death were hemorrhage from one or more metastatic sites (42{\%}) and pulmonary insufficiency (31{\%}). Factors primarily responsible for the treatment failures in these patients were: (1) presence of extensive disease at the time of initial treatment; (2) inadequate initial treatment; and (3) failure of presently used chemotherapy protocols in advanced disease. Secondary chemotherapy, radiation therapy to sites other than the brain, and adjuvant surgical procedures failed to improve survival in these high-risk patients.",
author = "{Lurain III}, {John Robert} and Brewer, {John I.} and Mazur, {Michael T.} and Torok, {Elizabeth E.}",
year = "1982",
month = "10",
day = "15",
doi = "10.1016/0002-9378(82)90242-3",
language = "English (US)",
volume = "144",
pages = "391--395",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

Fatal gestational trophoblastic disease : An analysis of treatment failures. / Lurain III, John Robert; Brewer, John I.; Mazur, Michael T.; Torok, Elizabeth E.

In: American journal of obstetrics and gynecology, Vol. 144, No. 4, 15.10.1982, p. 391-395.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fatal gestational trophoblastic disease

T2 - An analysis of treatment failures

AU - Lurain III, John Robert

AU - Brewer, John I.

AU - Mazur, Michael T.

AU - Torok, Elizabeth E.

PY - 1982/10/15

Y1 - 1982/10/15

N2 - Forty-eight of 399 patients referred to the John I. Brewer Trophoblastic D isease Center of Northwestern University Medical School from 1962 to 1979 for treatment of gestational trophoblastic disease (invasive mole or choriocarcinoma) died. All patients who died had histologically documented metastatic choriocarcinoma. The time from pregnancy event to treatment was >4 months and/or the pretreatment human chorionic gonadotropin titer was >100,000 IU/L in 64% of these patients. Seventy-one percent of fatal cases developed in association with term pregnancies, abortions, or ectopic pregnancies rather than hydatidiform moles. Fifty percent of patients who died had metastases to the liver, brain, and/or peritoneal cavity when they first presented for treatment. The most common causes of death were hemorrhage from one or more metastatic sites (42%) and pulmonary insufficiency (31%). Factors primarily responsible for the treatment failures in these patients were: (1) presence of extensive disease at the time of initial treatment; (2) inadequate initial treatment; and (3) failure of presently used chemotherapy protocols in advanced disease. Secondary chemotherapy, radiation therapy to sites other than the brain, and adjuvant surgical procedures failed to improve survival in these high-risk patients.

AB - Forty-eight of 399 patients referred to the John I. Brewer Trophoblastic D isease Center of Northwestern University Medical School from 1962 to 1979 for treatment of gestational trophoblastic disease (invasive mole or choriocarcinoma) died. All patients who died had histologically documented metastatic choriocarcinoma. The time from pregnancy event to treatment was >4 months and/or the pretreatment human chorionic gonadotropin titer was >100,000 IU/L in 64% of these patients. Seventy-one percent of fatal cases developed in association with term pregnancies, abortions, or ectopic pregnancies rather than hydatidiform moles. Fifty percent of patients who died had metastases to the liver, brain, and/or peritoneal cavity when they first presented for treatment. The most common causes of death were hemorrhage from one or more metastatic sites (42%) and pulmonary insufficiency (31%). Factors primarily responsible for the treatment failures in these patients were: (1) presence of extensive disease at the time of initial treatment; (2) inadequate initial treatment; and (3) failure of presently used chemotherapy protocols in advanced disease. Secondary chemotherapy, radiation therapy to sites other than the brain, and adjuvant surgical procedures failed to improve survival in these high-risk patients.

UR - http://www.scopus.com/inward/record.url?scp=0019956629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019956629&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(82)90242-3

DO - 10.1016/0002-9378(82)90242-3

M3 - Article

C2 - 6289666

AN - SCOPUS:0019956629

VL - 144

SP - 391

EP - 395

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -